FREE $100K
Today Screener Big Ideas Track Record 💰 $100K Arena 🎲 Predictions 🏛️ Insiders 8 Analysts

Ultralife Corporation (ULBI) Insider, 13F Hedge Fund & Politician Buy/Sell Thermometer

$15.62 0.00% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $15.59

Ultralife Corporation (ULBI) carries a Roarable Rating of D+ (Sell) with 56/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D+ • SELL / AVOID Cap $260.3M
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on ULBI Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is ULBI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-03, Ultralife Corporation (NASDAQ: ULBI) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 56/100 at a spot price of $15.62 (0.00% 1D, market cap $260.3M). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 15/20, SEC Balance-Sheet Forensics 10/20, FRED Macro Regime Fit 13/20, and Executive Insider Alignment 7/20. Across 486 tracked Industrials issuers, ULBI ranks #167 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does ULBI compare to ELVA and CHPT in the Industrials sector?
▼

Within the Industrials sector (Industrial Machinery/Components), ULBI carries a Roarable D+ (56/100 RQD), trailing P/E of N/A, gross margin of 24.1%, and ROIC of -2.8%. By comparison, ELVA (Electrovaya Inc.) holds a D grade (44/100 RQD, P/E N/A, ROIC —, cap $264.0M) and CHPT (ChargePoint Holdings Inc.) posts a D- grade (37/100 RQD, P/E N/A, ROIC -35.0%, cap $256.2M). Among the 5-stock peer group, ULBI leads on earnings multiple (N/A) while ALTG leads on capital efficiency (4.0% ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for ULBI?
▼

Per ULBI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000875657), Ultralife Corporation generated $191.2M in revenue (+16.2% YoY), -$5.9M in net income, and $7.1M in free cash flow against $216.9M in total assets and $45.5M in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $15.59 (-0.19%)🧬 Disciplined Float (+0.16% YoY Shares)⚙️ Cash Engine: 11/20 (D+) • 3.7% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record: Scores of 56/100 (D+) historically posted market-perform odds over rolling 90-day windows (-0.4% avg 90D alpha vs SPY • 51.8% hit rate — wait for RQD ≥ 70 breakout).
Audit Bucket Track Record →
RQD QUANT TACHOMETERSELL / AVOID • D+
025507510056
JEV AI Jury Split (Battleground)
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D+ · Rk D+
Cash (11)Whales (15)SEC (10)Macro (13)CEO (7)
Each axis scored 0–20
12M PRICE TARGET CONE-0.9% Base Target
$18 Bull$15 Base$12 Bear
📬 FREE ULBI RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for ULBI)Realized 20D OHLCV Swing Band: ±7%
Deterministic 5-Pillar Attribution (56/100 Composite)
🔍 WHY ULBI SCORES 56/100 (D+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Whale & Options Positioning+15/20 pts (27% of score)

20D Institutional Volume Accumulation (±7% realized swing band)

▲ #2 Bullish Driver: Macro Regime Fit+13/20 pts (23% of score)

FRED Regime × Technicals: 99% of 52W Range • RSI-14 at 92 (OVERBOUGHT (>70))

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution7/20 pts (-13 pt drag)

Disciplined Float (+0.16% YoY Shares) & executive Form 4 sales trim 13 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
48
Grade D$6.17+1.9% Next Q
Q2 (-2Q)
51
Grade C-$6.29+1.1% Next Q
Q3 (-1Q)
53
Grade C-$6.36+145.6% Next Q
Current
56
Grade D+$15.62-0.4% Hist 90D α
Trajectory: D (48) → D+ (56)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the ULBI Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 56/100 (D+) score, ULBI faces multiple-compression risk if current valuation multiples re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Company executives have done more routine share selling than personal cash buying lately.

⚠️ Forensic Kill-Switch #2

Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($7.06) or 200D SMA ($6.56) invalidates the momentum regime and cuts Target Base ($15.48) toward Bear Floor ($12.07).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $ULBI• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “ULBI Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
SEC FORM 4 × 13F HEDGE FUNDS × CONGRESSIONAL STOCK ACT

ULBI Smart-Money Thermometer: NET EXECUTIVE TRIMMING / PROFIT-TAKING

Explore All 13F & Congress Whales →
▲ Disclosed Buys: 0 ($0)▼ Disclosed Sales: 0 ($0)

Wide-Open SEC Form 4, 13F & Congressional Disclosure Ledger (ULBI)

No recent open-market Form 4 cluster sales or emergency dumps flagged on ULBI. Visit the Global 13F & Congressional Whale Ledger for cross-market smart-money filings.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring ULBI)

  • ✓Walkthrough of ULBI's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
ULBI // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +135.95%⚡ TESTING RESISTANCE
2026-11-03O $15.62H $15.62L $15.62C $15.62VOL 282.8K
RES: $15.95SUP: $5.69SMA50: $7.06SMA200: $6.56
$16.41$13.36$10.31$7.26$4.21RES $15.95SUP $5.69$15.622026-05-042026-06-172026-08-042026-09-182026-11-03
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

ULBI Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle
8.0%/yr Implied 5Y Growth

vs. +16.2% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on ULBI today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for ULBI. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for ULBI today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (ULBI)

Industrials Rank #167 of 486 ⚔️ ELVA vs ULBI Full Matrix →

1. Head-to-Head Industrials Peer Comparison (ULBI vs. ELVA, CHPT, AZ, ALTG)

Industry: Industrial Machinery/Components (208 Tracked Issuers)

Across 486 tracked Industrials securities in the Roarable RQD universe, Ultralife Corporation (ULBI) ranks #167 by composite RQD confidence (56/100, grade D+) and #335 by equity capitalization ($260.3M). Within this direct 5-issuer industry benchmark cohort, ULBI leads on earnings valuation at N/A trailing P/E, while ALTG leads on capital efficiency and profitability with 4.0% ROIC and 25.9% gross margin. ULBI currently leads its immediate peer cohort in composite quantitative strength at 56/100 (D+).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
ULBI ACTIVE
Ultralife Corporation
D+ 56/100 — 24.1% -2.8% 0.00% $260.3M Benchmark Subject
ELVA
Electrovaya Inc.
D 44/100 — — — -0.19% $264.0M /elva-vs-ulbi →
CHPT
ChargePoint Holdings Inc.
D- 37/100 — 30.5% -35.0% +3.56% $256.2M /chpt-vs-ulbi →
AZ
A2Z Cust2Mate Solutions Corp.
D 51/100 — — — -0.16% $275.0M /az-vs-ulbi →
ALTG
Alta Equipment Group Inc. (Class A)
D 51/100 — 25.9% 4.0% +0.81% $241.1M /altg-vs-ulbi →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0000875657 ↗

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Ultralife Corporation (ULBI) reported GAAP revenue of $191.2M (+16.2% vs. FY2024 revenue of $164.5M , and +20.5% cumulative change since FY2023) , GAAP net income of -$5.9M, operating cash flow of $11.0M, and free cash flow of $7.1M (-51.6% YoY). On the balance sheet, ULBI closed FY2025 with $216.9M in total assets against $45.5M in total debt (Altman Z-Score: 2.71, Piotroski F-Score: 6/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $191.2M -$5.9M $11.0M $7.1M $216.9M $45.5M
FY2024 (FY) 2024-12-31 $164.5M $6.3M $16.6M $14.7M $220.5M $51.5M
FY2023 (FY) 2023-12-31 $158.6M $7.2M $1.9M $1.9M — —

3. ULBI Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is ULBI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-03, Ultralife Corporation (NASDAQ: ULBI) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 56/100 at a spot price of $15.62 (0.00% 1D, market cap $260.3M). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 15/20, SEC Balance-Sheet Forensics 10/20, FRED Macro Regime Fit 13/20, and Executive Insider Alignment 7/20. Across 486 tracked Industrials issuers, ULBI ranks #167 in composite RQD confidence.

How does ULBI compare to ELVA and CHPT in the Industrials sector?

Within the Industrials sector (Industrial Machinery/Components), ULBI carries a Roarable D+ (56/100 RQD), trailing P/E of N/A, gross margin of 24.1%, and ROIC of -2.8%. By comparison, ELVA (Electrovaya Inc.) holds a D grade (44/100 RQD, P/E N/A, ROIC —, cap $264.0M) and CHPT (ChargePoint Holdings Inc.) posts a D- grade (37/100 RQD, P/E N/A, ROIC -35.0%, cap $256.2M). Among the 5-stock peer group, ULBI leads on earnings multiple (N/A) while ALTG leads on capital efficiency (4.0% ROIC).

What are the biggest fundamental strengths and SEC risk factors for ULBI?

Per ULBI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000875657), Ultralife Corporation generated $191.2M in revenue (+16.2% YoY), -$5.9M in net income, and $7.1M in free cash flow against $216.9M in total assets and $45.5M in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.

Where is ULBI trading relative to its 50-day, 200-day, and 52-week technical levels?

ULBI last traded at $15.62 (0.00% on volume of 248,411 shares), positioning the stock +121.25% above its 50-day simple moving average ($7.06) and +138.11% above its 200-day simple moving average ($6.56). Across its 52-week range of $4.90 to $15.67, ULBI sits at the 99.5% percentile with a 14-day RSI of 93.4 (OVERBOUGHT (>70)) and an implied next-earnings move of ±7.0% ($14.53 to $16.71).

ROARABLE RATING BRIEF • RQD 56/100 (D+) ✓ SEC XBRL & RQD VERIFIED

ULBI — Ultralife Corporation: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2025-12-31

1. Roarable Rating Brief: What This Means to a Prospective Investor

Ultralife Corporation (ULBI) earns a live Roarable RQD composite score of 56/100, corresponding to a D+ letter grade (Roarable Sell) at a spot price of $15.62 (0.00% 1D, market capitalization $260.3M).

  • Fundamental Cash Engine (11/20): Anchored by return on invested capital (ROIC) of -2.8%, gross margin of 24.1%, operating margin of -3.1%, and free cash flow yield of 2.73%.
  • Whale 13F & Options Flow (15/20) + Insider Conviction (7/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
  • Macro Regime Fit (13/20) + Forensic Balance Sheet (10/20): Incorporates a 1.00x equity beta, Altman Z-Score of 2.71, Piotroski F-Score of 6/9, and Debt/Equity of 0.35x.

2. Business Model, Unit Margins & SEC Financial Trajectory

Ultralife Corporation (ULBI) is a NASDAQ-listed issuer classified in the Industrials sector and the Industrial Machinery/Components industry. The company's market capitalization is listed at $0.3B in the profile.

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), Ultralife Corporation (ULBI) reported $191.2M in annual revenue (up from $164.5M in FY2024, +16.2% YoY) and -$5.9M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($158.6M revenue, $7.2M net income) through FY2025, ULBI scaled operating cash flow to $11.0M and free cash flow to $7.1M, backed by $216.9M in total assets against $45.5M in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

  • 🐂 Primary Bull Case (D+ • RQD 56/100): Big institutional funds and options desks are actively positioning on the bullish side. Free cash flow yield of 2.73% and institutional whale pillar of 15/20. With Fundamental Cash Engine at 11/20 and Institutional Whale Flow at 15/20, sustained execution supports upside toward the upper end of the $4.90 – $15.67 52-week range.
  • 🐻 Primary Bear Case & Valuation Risk: Company executives have done more routine share selling than personal cash buying lately. Investors must weigh current valuation against -3.1% operating margins and a 1.00x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

Operating in Industrial Machinery/Components (Industrials), ULBI carries a macro regime beta of 1.00 and gross margin of 24.1%.

  • Key Question #1: Can ULBI sustain or expand its -3.1% operating margin and -2.8% ROIC against Industrial Machinery/Components peers over the next 4 quarters?
  • Key Question #2: Following FY2025 revenue of $191.2M and free cash flow of $7.1M, how will capital allocation balance growth reinvestment against $45.5M in total debt?
  • Key Question #3: How sensitive is ULBI's equity valuation to Industrials capital spending cycles and macro interest-rate shifts (Beta 1.00x)?

ULBI Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Ultralife Corporation (ULBI) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to ULBI Debate Forum (3) ↓
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

ULBI Bull vs. Bear Conversation Board — What's Your Call at $15.62?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON ULBI 🐻 33% BEARISH CONVICTION
1. Pick Your Side on ULBI:
💡 Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
SI SiliconVal_Bull RQD DEBATE OPENER • Growth & Tech Investor 🐂 BULLISH 🎯 Target: $18.59 (+19.0%)
📌 Pinned Debate

Reported EnerSys cash takeover headlines, with a 166% premium and 40.3% holder backing, point to a potential acquisition-driven price c

Don't sleep on ULBI's setup in Industrials. Reported EnerSys cash takeover headlines, with a 166% premium and 40.3% holder backing, point to a potential acquisition-driven price catalyst.. Beta of 1.0 means it moves fast when momentum turns, and the 5-pillar RQD gauge (56/100) backs up the fundamental quality.

CapAlloc_Nerd 🐂 BULL

@SiliconVal_Bull Agree on the RQD 56/100 quality, though with 1.0 beta I'm scaling in with half-size at $15.62 and keeping dry powder in case we test $14.53.

BE BearTrap_Alert RQD DEBATE OPENER • Cycle Peak Watcher 🐻 BEARISH 🎯 Target: $11.87 (-24.0%)
Spot @ $15.62

Negative ROIC of -2.8% and a -3.1% operating margin, with FY 2025 operating income falling to -$5.9M, show weak reported operating retu

Sitting on the sidelines or leaning short ULBI above $15.62. Negative ROIC of -2.8% and a -3.1% operating margin, with FY 2025 operating income falling to -$5.9M, show weak reported operating returns.. Until Fundamental Cash Engine (11/20) and FCF yield (2.73%) inflect higher, upside is capped near $15.67.

LIVE TAPE SPY $752.10 -1.80% QQQ $681.09 -3.60% DIA $519.34 -1.08% IWM $279.14 -1.68% NVDA $202.06 -1.26% AAPL $338.32 -1.83% MSFT $507.12 -2.83% TSLA $403.82 +1.00% PLTR $178.34 -3.13% SOFI $16.60 -0.95% IBIT $43.35 -5.42% GLD $361.65 -3.59%